Molecular Diagnostics Market

Molecular Diagnostics Market

The Molecular Diagnostics Market is valued at USD 15.9 billion in 2024 growing at a CAGR of 6.2% during the forecast period 2024-2035.

Molecular diagnostic tests are designed to detect specific sequences in human genomic samples, such as DNA or RNA, to diagnose specific diseases. These tests also aim to identify single nucleotide polymorphisms, deletions, rearrangements, and insertions in genetic sequences. It is worth noting that molecular diagnostics is a subset of the in vitro diagnostics market, which, according to the World Health Organization, consists of over 40,000 available products. This vast array of products highlights the critical role of diagnostics in healthcare, with over 70% of healthcare decisions being made based on laboratory test results, showcasing the importance of such diagnostic tools in patient care.

Molecular diagnostic tests play a pivotal role in diagnosing various diseases, monitoring healthcare responses, and predicting healthcare outcomes. Given the benefits offered by such diagnostic solutions in providing rapid results and improving patient outcomes, the global molecular diagnostics market is expected to experience substantial growth at a healthy CAGR during the forecast period. This market growth can be attributed to several factors, including the increasing demand for point-of-care diagnostics devices, rapid diagnostic testing, and the rising prevalence of infectious diseases.

Key Market Segments

Test Type

• Laboratory Testing
• Point-of-Care Testing

Type of Offering / Product Type

• Reagents
• Instruments
• Services

Type of Sample

• Blood, Serum and Plasma
• Urine
• Others

Type of Technology

• Polymerase Chain Reaction (PCR)
• In situ Hybridization
• Isothermal Nucleic Acid Amplification Technology
• Next Generation Sequencing
• Microarrays
• Mass Spectrometry
• Others

Therapeutic Area

• Cardiovascular Diseases
• Genetic Diseases
• Infectious Diseases
• Neurological Diseases
• Oncological Disorders
• Others

End Users

• Hospitals
• Laboratories
• Others

Geographical Regions

• North America (US, Canada)
• Europe (Austria, Belgium, France, Germany, Italy, Netherlands,

Poland, Spain, Switzerland, UK, Rest of the Europe)

• Asia (China, India, Indonesia, Japan, Singapore,

South Korea, Thailand, Rest of Asia)

• Latin America (Argentina, Brazil, Mexico,

Rest of Latin America)

• Middle East and North Africa (Egypt, Israel, Saudi Arabia,

Rest of Middle East and North Africa)

• Rest of the World (Australia and New Zealand)

Research Coverage:

• A brief overview of molecular diagnostics, featuring information on key technologies employed in molecular diagnostic solutions and challenges associated with molecular diagnostics domain. Further, this chapter features recent advancements and future perspectives of this market space.
• An in-depth analysis of the factors that can impact the growth of the market. It also features identification and market analysis of key drivers, potential restraints, emerging opportunities, and existing challenges.
• A detailed estimate of the current molecular diagnostics market size, opportunity and the future growth potential, over the next decade. Based on multiple parameters, likely adoption trends and through validations from credible sources, we have provided an informed estimate on the market evolution during the forecast period 2024-2035. The report also features likely distribution of the current and forecasted opportunity. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base and optimistic scenarios, representing different tracks of the industry’s growth.
• A detailed projection of current market size and future opportunity in the molecular diagnostics market across different test types, such as laboratory testing and point-of-care testing.
• A detailed projection of the current and future molecular diagnostics industry across different types of offerings, such as instruments, reagents and services.
• A detailed projection of the current and future market for molecular diagnostics across different types of samples, such as blood, serum and plasma, urine and others.
• A detailed projection of the current and future molecular diagnostics market across different types of technologies, such as PCR, in situ hybridization, isothermal nucleic acid amplification technology, next generation sequencing, microarrays, mass spectrometry and others.
• A detailed projection of the current and future molecular diagnostic industry across different therapeutic areas, such as cardiovascular diseases, genetic diseases, infectious diseases, neurological diseases, oncological disorders and others.
• A detailed projection of the current and future molecular diagnostics market across different end users, such as hospitals, laboratories and others.
• A detailed projection of the current and future molecular diagnostic industry across Geographical Regions, such as North America (US, Canada), Europe (Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland, UK, Rest of the Europe), Asia (China, India, Indonesia, Japan, Singapore, South Korea, Thailand, Rest of Asia), Latin America (Argentina, Brazil, Mexico, Rest of Latin America), Middle East and North Africa (Egypt, Israel, Saudi Arabia, Rest of Middle East and North Africa) and Rest of the World (Australia and New Zealand).
• A detailed analysis showcasing the segmentation of the molecular diagnostics industry among the leading players engaged in this domain.
• An overview of the current market landscape of leading molecular diagnostics companies, along with company overview (information on their year of establishment, company size, company ownership and location of headquarters). Further, it highlights a detailed assessment of the molecular diagnostic solutions based on several relevant parameters, such as type of technology used (PCR, next generation sequencing, microarrays, mass spectrometry, isothermal nucleic acid amplification technology, and in situ hybridization), diagnostic applications (infectious, genetic, gynecological, oncological, sexually transmitted infections / diseases, and neurological).
• An insightful competitiveness analysis of the leading molecular diagnostics companies, based on several relevant parameters, such as years of experience and company competitiveness (based on annual revenue, type of technology and diagnostic applications).
• Elaborate profiles of various prominent players segregated based on various geographical regions, that are currently involved in the molecular diagnostics market. Each company profile features a brief overview of the company (including information on its year of establishment, number of employees, location of headquarters and key members of the executive team), financial information, molecular diagnostic offerings and details related to its recent developments and an informed future outlook.
• A qualitative porter’s five forces analysis, highlighting the five competitive forces prevalent in the market, including threats for new entrants, bargaining power of buyers, bargaining power of suppliers, threats of substitute products and rivalry among existing competitors.

Key Benefits of Buying this Report

• The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
• Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
• The report provides stakeholders with a pulse on the Molecular Diagnostics Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.

Leading Market Companies

• Abbott Laboratories
• Agilent Technologies
• Becton Dickinson
• BGI Genomics
• bioMérieux
• Bio-Rad
• Danaher
• DiaSorin
• Grifols
• Hologic
• Illumina
• Qiagen
• QuidelOrtho
• Revvity
• Roche
• Sansure
• Seegene
• Siemens Healthineers
• Sysmex
• Thermo Fisher Scientific